Ask a Rev Cycle Expert: Injection Procedure for C9094 Sutimlimab-jome?
The drug ENJAYMO™ has been approved by the U.S. Federal Drug Administration (FDA) and assigned to Healthcare Common Procedure Coding System (HCPCS) C9094 Inj, sutimlimab-jome, 10 mg. The drug has been ordered by an oncologist for Cold Agglutinin Disease. What would be the appropriate administration code for the first hour of administration, Current Procedural Terminology (CPT®) code 96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug or 96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour?
Learn More
